(WCH) Wacker Chemie - Ratings and Ratios
Silicone, Polymer, Biosolution, Polysilicon, Chemical
Dividends
| Dividend Yield | 3.83% |
| Yield on Cost 5y | 2.84% |
| Yield CAGR 5y | 0.00% |
| Payout Consistency | 80.5% |
| Payout Ratio | 5.8% |
| Risk via 10d forecast | |
|---|---|
| Volatility | 35.2% |
| Value at Risk 5%th | 55.0% |
| Relative Tail Risk | -4.88% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.04 |
| Alpha | -12.48 |
| CAGR/Max DD | -0.24 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.496 |
| Beta | 0.345 |
| Beta Downside | 0.580 |
| Drawdowns 3y | |
|---|---|
| Max DD | 58.48% |
| Mean DD | 32.54% |
| Median DD | 31.55% |
Description: WCH Wacker Chemie November 09, 2025
Wacker Chemie AG (XETRA: WCH) operates globally through four core divisions – Silicones, Polymers, Biosolutions, and Polysilicon – delivering a portfolio that spans silicone intermediates, polymeric additives for construction and coatings, custom biotech fine chemicals, and hyper-pure polysilicon for semiconductor and solar applications.
In FY 2023 the group generated €5.4 billion in revenue, with the Silicones segment accounting for roughly 55 % of sales and delivering an adjusted EBITDA margin of 13 %. The Polysilicon division, a strategic growth engine, runs a capacity of about 30 kt/year and benefitted from a 12 % YoY increase in average realized prices driven by tightening supply in the solar-grade silicon market.
Key economic drivers for Wacker include the accelerating rollout of photovoltaic installations (global PV capacity grew 23 % in 2023) and the ongoing semiconductor fab expansion, both of which lift demand for high-purity polysilicon. At the same time, specialty-chemical pricing is sensitive to raw-material costs (e.g., silicon, ethylene) and cyclical demand in construction and automotive sectors, which introduces earnings volatility.
For a deeper, data-rich assessment of Wacker’s valuation dynamics and scenario analysis, you may find the analyst tools on ValueRay worth exploring.
Piotroski VR‑10 (Strict, 0-10) 4.0
| Net Income (21.7m TTM) > 0 and > 6% of Revenue (6% = 334.0m TTM) |
| FCFTA -0.03 (>2.0%) and ΔFCFTA 3.51pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 42.63% (prev 40.43%; Δ 2.20pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.05 (>3.0%) and CFO 386.4m > Net Income 21.7m (YES >=105%, WARN >=100%) |
| Net Debt (900.0m) to EBITDA (450.0m) ratio: 2.0 <= 3.0 (WARN <= 3.5) |
| Current Ratio 3.02 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (49.7m) change vs 12m ago -0.29% (target <= -2.0% for YES) |
| Gross Margin 15.28% (prev 15.22%; Δ 0.05pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 63.61% (prev 64.53%; Δ -0.91pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 5.40 (EBITDA TTM 450.0m / Interest Expense TTM 19.9m) >= 6 (WARN >= 3) |
Altman Z'' 4.37
| (A) 0.28 = (Total Current Assets 3.55b - Total Current Liabilities 1.17b) / Total Assets 8.56b |
| (B) 0.46 = Retained Earnings (Balance) 3.90b / Total Assets 8.56b |
| (C) 0.01 = EBIT TTM 107.4m / Avg Total Assets 8.75b |
| (D) 0.94 = Book Value of Equity 3.90b / Total Liabilities 4.14b |
| Total Rating: 4.37 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 33.40
| 1. Piotroski 4.0pt |
| 2. FCF Yield -5.76% |
| 3. FCF Margin -4.76% |
| 4. Debt/Equity 0.46 |
| 5. Debt/Ebitda 2.0 |
| 6. ROIC - WACC (= -3.01)% |
| 7. RoE 0.49% |
| 8. Rev. Trend -68.52% |
| 9. EPS Trend -89.24% |
What is the price of WCH shares?
Over the past week, the price has changed by +0.15%, over one month by -1.26%, over three months by +7.88% and over the past year by -2.86%.
Is WCH a buy, sell or hold?
What are the forecasts/targets for the WCH price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 68.1 | 2.5% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 65.3 | -1.6% |
WCH Fundamental Data Overview November 27, 2025
Market Cap EUR = 3.38b (3.38b EUR * 1.0 EUR.EUR)
P/E Trailing = 148.4091
P/E Forward = 21.9298
P/S = 0.6072
P/B = 0.7836
P/EG = 2.86
Beta = 0.786
Revenue TTM = 5.57b EUR
EBIT TTM = 107.4m EUR
EBITDA TTM = 450.0m EUR
Long Term Debt = 1.43b EUR (from longTermDebt, last fiscal year)
Short Term Debt = 221.2m EUR (from shortTermDebt, last fiscal year)
Debt = 1.95b EUR (from shortLongTermDebtTotal, last fiscal year)
Net Debt = 900.0m EUR (from netDebt column, last fiscal year)
Enterprise Value = 4.61b EUR (3.38b + Debt 1.95b - CCE 719.9m)
Interest Coverage Ratio = 5.40 (Ebit TTM 107.4m / Interest Expense TTM 19.9m)
FCF Yield = -5.76% (FCF TTM -265.2m / Enterprise Value 4.61b)
FCF Margin = -4.76% (FCF TTM -265.2m / Revenue TTM 5.57b)
Net Margin = 0.39% (Net Income TTM 21.7m / Revenue TTM 5.57b)
Gross Margin = 15.28% ((Revenue TTM 5.57b - Cost of Revenue TTM 4.72b) / Revenue TTM)
Gross Margin QoQ = 11.50% (prev 11.70%)
Tobins Q-Ratio = 0.54 (Enterprise Value 4.61b / Total Assets 8.56b)
Interest Expense / Debt = 0.36% (Interest Expense 7.10m / Debt 1.95b)
Taxrate = -68.93% (out of range, set to none) (33.5m / -48.6m)
NOPAT = unknown (EBIT/Op.Income or Taxrate missing)
Current Ratio = 3.02 (Total Current Assets 3.55b / Total Current Liabilities 1.17b)
Debt / Equity = 0.46 (Debt 1.95b / totalStockholderEquity, last quarter 4.27b)
Debt / EBITDA = 2.0 (Net Debt 900.0m / EBITDA 450.0m)
Debt / FCF = -3.39 (negative FCF - burning cash) (Net Debt 900.0m / FCF TTM -265.2m)
Total Stockholder Equity = 4.47b (last 4 quarters mean from totalStockholderEquity)
RoA = 0.25% (Net Income 21.7m / Total Assets 8.56b)
RoE = 0.49% (Net Income TTM 21.7m / Total Stockholder Equity 4.47b)
RoCE = 1.82% (EBIT 107.4m / Capital Employed (Equity 4.47b + L.T.Debt 1.43b))
RoIC = 1.61% (EBIT 107.4m / (Assets 8.56b - Curr.Liab 1.17b - Cash 719.9m))
WACC = 4.63% (E(3.38b)/V(5.33b) * Re(7.29%) + (debt cost/tax rate unavailable))
Discount Rate = 7.29% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Shares Correlation 3-Years: 0.0 | Cagr: 0.0%
Fair Price DCF = unknown (Cash Flow -265.2m)
EPS Correlation: -89.24 | EPS CAGR: -61.96% | SUE: -3.65 | # QB: 0
Revenue Correlation: -68.52 | Revenue CAGR: -5.97% | SUE: 0.04 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.25 | Chg30d=-0.560 | Revisions Net=+0 | Analysts=1
EPS next Year (2026-12-31): EPS=1.66 | Chg30d=-0.007 | Revisions Net=-4 | Growth EPS=+430.1% | Growth Revenue=+3.0%